FDA Clears Encora X1 Wrist-Worn Device for Essential Tremor
The Encora X1 is a noninvasive, wrist-worn neurostimulation device designed to reduce hand tremors and improve daily function in adults with essential tremor.
The Encora X1 is a noninvasive, wrist-worn neurostimulation device designed to reduce hand tremors and improve daily function in adults with essential tremor.
Contrary to previous research, a new study of female participants finds no link between migraine and the risk of developing Parkinson’s.
The Koneksa Academic Partnership Program for Parkinson’s Disease (KAPP-PD) will incorporate its Neuroscience Toolkit into research programs.
ENT-01 is safe for up to 25 days of treatment and helps improve constipation and possibly neurological symptoms in Parkinson’s patients.
Read MoreResearchers used artificial intelligence techniques to estimate parameters such as step length, width, and velocity to diagnose Parkinson’s.
Read MoreDigital health start-up H2o therapeutics received 510(k) marketing clearance from the...
Read MoreInsightec publishes a follow-up study of unilateral MRI-guided focused ultrasound thalamotomy for essential tremor.
Read MorePeople with weight changes soon after being diagnosed with Parkinson’s disease may be more likely to have changes in their thinking skills than people who maintain their weight, according to a recent study.
Read MoreCala TAPS therapy reduces essential tremor with no loss of effect over time and improves patient quality of life, a new study suggests.
Read MoreThe Muscular Dystrophy Association announces the awarding of 70 new grants totaling over $17 million toward neuromuscular disease research.
Read MoreFlexible implantable electronics are a step closer toward clinical applications thanks to a recent breakthrough technology.
Read MorePatients with essential tremor and Parkinson’s disease have a higher prevalence of comorbidities, according to new research from Cala Health.
Read MoreFocused ultrasound offers treatment for people suffering from essential tremor, Parkinson’s disease, and other neurological disorders.
Read MoreOlder people taking statins have a lower chance of developing parkinsonism later compared to people who weren’t taking statins, per research.
Read MoreJOGO-Gx, a digital therapeutic that taps into the neuroplasticity of the brain using biofeedback, shows early success as a Parkinson’s treatment.
Read MoreNew coding and coverage by commercial and government payors makes it easier for physicians to prescribe and patients to afford Cala Health’s clinically proven treatment for essential tremor, Cala Trio therapy, the company notes in a media release.
Read MoreA common gene mutation for Parkinson’s disease drives mislocalization of iron in activated microglia, according to a study published recently in PLOS Biology, by Mark Cookson of the National Institute on Aging and colleagues.
Read MoreTranscranial direct current stimulation (tDCS) can increase the benefits of aerobic exercise and improve the gait of patients with Parkinson’s disease immediately after a session, researchers suggest, in Neurorehabilitation & Neural Repair.
Read More